Preferred Label : Erythroleukemia, familial, susceptibility to;
Symbol : FERLK;
CISMeF acronym : FERLK;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Leukemia, acute myelogenous, m6; Di guglielmo disease, familial;
Description : Familial erythroleukemia is a leukemic or preleukemic state in which red cell proliferation
is the predominant feature. Hematologic characteristics include particularly ineffective
and hyperplastic erythropoiesis with megaloblastic components accompanied by myeloblastic
proliferation of varying degree (Park et al., 2002). Park et al. (2002) discussed
the evolution of the definition of 'erythroleukemia,' which is considered by most
to be a subtype of acute myelogenous leukemia (AML; 601626). Controversy about the
precise definition of erythroleukemia revolves around the number or percentage of
erythroblasts and myeloblasts found in the bone marrow and peripheral circulation.
In the French-American-British (FAB) classification system (Bennett et al., 1985),
it is known as AML-M6, whereas in the revised World Health Organization (WHO) classification
system (Harris et al., 1999), it is known as 'AML, not otherwise categorized' (Zini
and D'Onofrio, 2004).;
Inheritance : Autosomal dominant;
Molecular basis : Susceptibility conferred by mutation in the V-ERB-B2 avian erythroblastic leukemia
viral oncogene homolog 3 gene (ERBB3, 190151.0002);
Neoplasia : Possible increased risk of solid malignant tumors;
Prefixed ID : #133180;
Origin ID : 133180;
UMLS CUI : C5552985;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)